Xiaofang Ding1, Han Huang1, Lili Zhong1, Min Chen1, Fang Peng1, Bing Zhang1, Xinyu Cui2, Xiu-An Yang2. 1. Department of Pediatrics, First Affiliated Hospital of Hunan Normal University/Hunan Provincial People's Hospital, Changsha, China. 2. Department of Biochemistry, School of Basic Medical Science, Chengde Medical University, Chengde, China.
Abstract
Objective: This study presents a relatively rare case of disseminated Talaromyces marneffei (T. marneffei) infection in an HIV-negative patient. Methods: An 8-month-old girl was hospitalized because of uncontrollable fever and cough for 6 days. Routine laboratory tests, biochemical detection, immunological tests, pathogenic examination, and imaging inspection were performed. Genetic tests of trio whole genome sequencing (Trio-WES), trio copy number sequencing (Trio-CNVseq), and Sanger sequencing were conducted to identify pathogenic variants. In silico analysis of the sequence alignment and structural modeling results was carried out to study the possible pathogenicity of the identified variant. Western blotting was performed to investigate the expression of the identified gene at the protein level. Results: Enhanced CT and MRI scanning demonstrated thymic dysplasia, diffuse pulmonary and liver nodules, and many balloon-like air sacs in both lungs. The white blood cell count, neutrophil count, and neutrophil ratio were normal or elevated. The patient was HIV-negative and bone marrow and blood culture showed T. marneffei infection. Total lymphocyte count, CD3+ T lymphocyte count, CD3+CD4+ T lymphocyte count, CD3+CD8+ T lymphocyte count, and NK cell count decreased, while the number of CD19 positive B cells increased. However, the ratio of CD3+CD4+:CD3+CD8+ T cells increased. Trio-WES identified a homozygous private variant of NM_006509: c.400_c.401insAGC/p.Lys134 delinsLysGln in RELB and Sanger sequencing validated the result. Structural modeling indicated that the variant may be pathogenic. Reverse transcription-polymerase chain reaction and Western blot analysis showed that the expression of RelB in the patient was lower than that in the healthy controls at mRNA and protein levels. Conclusion: This is the first report on disseminated T. marneffei infection in a patient with a homozygous private variant of RELB.
Objective: This study presents a relatively rare case of disseminated Talaromyces marneffei (T. marneffei) infection in an HIV-negative patient. Methods: An 8-month-old girl was hospitalized because of uncontrollable fever and cough for 6 days. Routine laboratory tests, biochemical detection, immunological tests, pathogenic examination, and imaging inspection were performed. Genetic tests of trio whole genome sequencing (Trio-WES), trio copy number sequencing (Trio-CNVseq), and Sanger sequencing were conducted to identify pathogenic variants. In silico analysis of the sequence alignment and structural modeling results was carried out to study the possible pathogenicity of the identified variant. Western blotting was performed to investigate the expression of the identified gene at the protein level. Results: Enhanced CT and MRI scanning demonstrated thymic dysplasia, diffuse pulmonary and liver nodules, and many balloon-like air sacs in both lungs. The white blood cell count, neutrophil count, and neutrophil ratio were normal or elevated. The patient was HIV-negative and bone marrow and blood culture showed T. marneffei infection. Total lymphocyte count, CD3+ T lymphocyte count, CD3+CD4+ T lymphocyte count, CD3+CD8+ T lymphocyte count, and NK cell count decreased, while the number of CD19 positive B cells increased. However, the ratio of CD3+CD4+:CD3+CD8+ T cells increased. Trio-WES identified a homozygous private variant of NM_006509: c.400_c.401insAGC/p.Lys134 delinsLysGln in RELB and Sanger sequencing validated the result. Structural modeling indicated that the variant may be pathogenic. Reverse transcription-polymerase chain reaction and Western blot analysis showed that the expression of RelB in the patient was lower than that in the healthy controls at mRNA and protein levels. Conclusion: This is the first report on disseminated T. marneffei infection in a patient with a homozygous private variant of RELB.
Authors: Pamela P W Lee; Huawei Mao; Wanling Yang; Koon-Wing Chan; Marco H K Ho; Tsz-Leung Lee; Jasper F W Chan; Patrick C Y Woo; Wenwei Tu; Yu-Lung Lau Journal: J Allergy Clin Immunol Date: 2013-11-01 Impact factor: 10.793
Authors: Ivan K Chinn; Alice Y Chan; Karin Chen; Janet Chou; Morna J Dorsey; Joud Hajjar; Artemio M Jongco; Michael D Keller; Lisa J Kobrynski; Attila Kumanovics; Monica G Lawrence; Jennifer W Leiding; Patricia L Lugar; Jordan S Orange; Kiran Patel; Craig D Platt; Jennifer M Puck; Nikita Raje; Neil Romberg; Maria A Slack; Kathleen E Sullivan; Teresa K Tarrant; Troy R Torgerson; Jolan E Walter Journal: J Allergy Clin Immunol Date: 2019-09-27 Impact factor: 10.793
Authors: R A Samson; N Yilmaz; J Houbraken; H Spierenburg; K A Seifert; S W Peterson; J Varga; J C Frisvad Journal: Stud Mycol Date: 2011-11-15 Impact factor: 16.097
Authors: Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm Journal: Genet Med Date: 2015-03-05 Impact factor: 8.822
Authors: Capucine Picard; H Bobby Gaspar; Waleed Al-Herz; Aziz Bousfiha; Jean-Laurent Casanova; Talal Chatila; Yanick J Crow; Charlotte Cunningham-Rundles; Amos Etzioni; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Hans D Ochs; Eric Oksenhendler; Jennifer Puck; Mimi L K Tang; Stuart G Tangye; Troy R Torgerson; Kathleen E Sullivan Journal: J Clin Immunol Date: 2017-12-11 Impact factor: 8.317
Authors: Charlotte A Heinen; Aldo Jongejan; Peter J Watson; Bert Redeker; Anita Boelen; Olga Boudzovitch-Surovtseva; Francesca Forzano; Roel Hordijk; Richard Kelley; Ann H Olney; Mary Ella Pierpont; G Bradley Schaefer; Fiona Stewart; A S Paul van Trotsenburg; Eric Fliers; John W R Schwabe; Raoul C Hennekam Journal: J Med Genet Date: 2016-01-14 Impact factor: 6.318